AI can improve ovarian cancer diagnoses
On Jan. 2, 2025, an international study led by researchers at Karolinska Institutet in Sweden shows that AI-based…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
U.S. FDA Approved Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
On Dec. 20, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BRAFTOVI® (encorafenib)…
Karmanos Cancer Institute First in the World to use FDA-approved Radiofrequency Electromagnetic Device to Treat Liver Cancer
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
AI-Based Tool Offers Exciting Advancement in Pancreatic Cancer Diagnostics
On Dec. 12, 2024, a study co-lead by researchers from the University of British Columbia, Vancouver General Hospital…
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
Massachusetts General Hospital Received Transformational Gift of $100 Million from Herb Chambers to Revolutionize Cancer Care for Patients and Families
On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…
Biotechnology | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved AstraZeneca’s Imfinzi for limited-stage small cell lung cancer
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
Nanopore direct RNA sequencing finds cancer’s ‘fingerprint’ improved early detection
On Dec. 4, 2024, researchers at the Centre for Genomic Regulation (CRG) in Barcelona announced they had discovered…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Radiology | Therapeutics
Study revealed how deadly brain tumor evades treatment; identifies potential new treatment strategy
On Nov. 21, 2024, a study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why…
State cancer agency awarded $89 million in grants to Texas institutions and companies
On Nov. 20, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Biotechnology | CDC | FDA | Genomics | Medical Device | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress
White House Released Report on Growing U.S. Biomanufacturing Capacity for the American Bioeconomy
On Nov. 15, 2024, the White House Office of Science and Technology Policy released a report on Building…
Biotechnology | Diagnostics | Disease | Neurology | Oncology | Therapeutics
new Glioblastoma treatment attacks brain tumors from multiple angles
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
Combination approach showed promise for treating rare, aggressive cancers
On Nov. 12, 2024, a research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that…
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences and Cleveland Clinic Presented Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
Biology | Biotechnology | Diagnostics | Genomics | Oncology
How ecDNA Fuels Cancer by Breaking the Laws of Biology
On Nov. 6, 2024, a trio of new studies with funding from Cancer Grand Challenges revealed the unfair advantage…
Global Disparities of Cancer Projected to increase by 2050
On Nov. 5, 2024, a cross-sectional study of data for 36 cancer types from 185 countries and territories…
New Computational Method Linked One Mammal’s Striking Longevity and Resistance to Cancer With ‘Dark Genome’
On Oct. 29, 2024, a study led by Andrei Gudkov, PhD, DSci, at Roswell Park Comprehensive Cancer Center support…
New Imaging Technique Accurately Detected Aggressive Kidney Cancer
On Oct. 29, 2024, a study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center (UCLA…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…
Oxford Researchers Received Funding to create world’s first ovarian cancer prevention vaccine
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
WHO added an HPV vaccine for single-dose use
On Oct. 4, 2024, the World Health Organization (WHO) announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine…
Combination Chemo Helps People with Leiomyosarcoma Live Longer
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy
On Oct. 2, 2024, a study from the GBD Tobacco Forecasting Collaborators reported that by accelerating the decline…
Breast Cancer Mortality Continues Three Decade Decline, but Steeper Increases in Incidence for Women <50
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
Biotechnology | Diagnostics | Environmental | Genomics | Infectious Disease | Medical Device | Nanotechnology | Oncology | Therapeutics | U.S. Congress
Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Environmental | Neurology | Oncology | Therapeutics | U.S. Congress
Golden Goose Award Honors Federally Funded Research in Bird Protection, Penguin Poop Monitoring, and AI
On Sept. 27, 2024, The Golden Goose Awards were announced for the 13th annual season, which spotlights obscure, silly…
Biotechnology | COVID-19 | Diagnostics | NIH | Oncology | Therapeutics | Women's Health
New cancer diagnoses did not rebound as expected following pandemic
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
Breast and ovarian cancer linked to thousands of gene variants
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
study found genetic variant for hair graying, susceptibility to skin melanoma in horses
On Sep. 4, 2024, an international consortium led by scientists from Uppsala University in Sweden reported that the…
False-positive mammogram results discourage some women from future screenings
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…